Patients with depression may develop atherosclerotic cardiovascular disease earlier and start treatment more often than those ...
The aim was to measure depression severity change from baseline to day five using the Montgomery-Åsberg Depression Rating ...
A neuroscientist, he employed a battery of high-tech tools in devising a fast-acting therapy that targets the area of the ...
Men suffer depression frequently, but often differently than women. Their symptoms are different and easily justified as ...
Scientists have found that the psychedelic DOI helped 'rewire' the brains of rats and influenced a brain pathway key to mental health that may improve treatment for depression.
"We've greatly misjudged and mis-prioritized the mental health of mothers in general and we've gotten a lot of it wrong." ...
A 12 mg dose of BPL-003 (mebufotenin benzoate nasal spray) administered eight weeks after an initial 12 mg, 8 mg or 0.3 mg ...
MedPage Today on MSN
FDA Broadens Caplyta Approval to Include Major Depression
The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive ...
Perhaps the most intriguing implication of recent breakthrough research lies in an unexpected connection: the most rigorous mechanistic dissection of rapid antidepressant action identifies adenosine ...
A large-scale randomized trial of texting therapy concluded that its outcomes were as good as video sessions in treating ...
Depression is one of the most widespread mental health disorders worldwide, characterized by persistent feelings of sadness, a loss of interest in everyday activities, dysregulated sleep or eating ...
A new study reveals text-based therapy is as effective as video counselling for mild to moderate depression. This finding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results